Malaysia will buy 12.8 million doses of coronavirus vaccine developed by Pfizer and BioNTech. Delivery of the first million doses is scheduled for Q1 2021, with 1.7 million, 5.8 million and 4.3 million doses scheduled for subsequent quarters.